Hetero, bungwe lodziwika bwino padziko lonse lapansi lazamankhwala lophatikizika ndi Shenzhen Beimei Pharmaceuticals pamodzi adalengeza kuti alandila chilolezo cha Oseltamivir phosphate pansi pa dzina la Oselavir® kuchokera kwa woyang'anira mankhwala ku China, National Medical Products Administration (NMPA).
Oseltamivir phosphate ndi mankhwala oletsa tizilombo toyambitsa matenda omwe amagwiritsidwa ntchito pochiza matenda owopsa a chimfine mwa akulu, achinyamata ndi ana (≥2 milungu yakubadwa). Oselavir® idzapezeka ku China mu mawonekedwe a mlingo - 12.5ml: 75mg ufa wa kuyimitsidwa pakamwa.
WHO ikuyerekeza kuti chimfine cha nyengo chikhoza kupha 290,000-650,000 chaka chilichonse chifukwa cha matenda opuma okha. Chiyerekezocho sichiganizira za imfa za matenda ena monga matenda a mtima, omwe angakhale okhudzana ndi chimfine.1.
Dr. Vamsi Krishna Bandi, Managing Director, Hetero Group of Companies anati, "Ndife okondwa kuti Hetero mogwirizana ndi Shenzhen Beimei Pharmaceuticals, China, adalandira chilolezo cha Oselavir® (Oseltamivir) ku China. Ichi ndi chivomerezo choyamba cha Hetero ku China, ndipo tadzipereka kubweretsa zinthu zambiri ku China posachedwa. "
Mayi Guangmei Wu, Purezidenti ndi CEO wa Shenzhen Beimei Pharmaceuticals "Ndikukhulupirirana komanso kuthandizirana pakati pa magulu a Beimei ndi Hetero, Oselavir® idakhazikitsidwa ku China ngati mankhwala oyamba aku China ovomerezeka a Oseltamivir mumkhalidwe wokhazikika wa ana. Ndikuthokoza gulu la Hetero chifukwa chogwira ntchito molimbika komanso khama pantchito yonse yopangira zinthu, kulembetsa kulembetsa ndikukonzekera kukhazikitsa Oselavir®. Tikuyembekezera kuwona zinthu zambiri ndi Hetero pazachipatala chapadziko lonse lapansi m'tsogolomu. "
